Kerrisdale Advisers »

Peregrine Pharmaceuticals shares owned by Kerrisdale Advisers

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Kerrisdale Advisers from 13F filings

Historical chart of Kerrisdale Advisers investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Kerrisdale Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Kerrisdale Advisers

Quarter filed Position value Share count Share price at filing
2023-09-30 $463k 49k 9.44